Infectious disease. Racing to defuse a bacterial time bomb.
Stone
Richard
R
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D023482:Bioterrorism; D016957:Burkholderia pseudomallei / Q000166:cytology / Q000235:genetics / Q000472:pathogenicity / Q000502:physiology; D002986:Clinical Trials as Topic; D019353:Endemic Diseases; D006801:Humans; D008554:Melioidosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D051379:Mice; D015995:Prevalence; D013785:Thailand / Q000453:epidemiology; D051195:Toll-Like Receptor 2 / Q000235:genetics / Q000502:physiology
D000900:Anti-Bacterial Agents; C493486:Tlr2 protein, mouse; D051195:Toll-Like Receptor 2